Changes in angiotensin type 1 receptor binding and angiotensin-induced pressor responses in the rostral ventrolateral medulla of angiotensinogen knockout mice

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 298, Issue 2, 2010, Pages

  Chen, Daian ^a   Hazelwood, Lisa ^a   Walker, Lesley L ^a   Oldfield, Brian J ^b   McKinley, Michael J ^a   Allen, Andrew M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Angiotensin II; Blood pressure; Brain microinjection; Brain reninangiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; GLUTAMIC ACID; PHENYLEPHRINE;

AMBIGUUS NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR COMMISSURE; ARTERIAL PRESSURE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BLOOD PRESSURE REGULATION; BRAIN NERVE CELL; BRAIN NUCLEUS; CARDIOVASCULAR SYSTEM; CELL STIMULATION; CONTROLLED STUDY; GENE DELETION; INFERIOR OLIVE; KNOCKOUT MOUSE; MAGNOCELLULAR NUCLEUS; MALE; MEDULLA OBLONGATA; MICROINJECTION; MOTONEURON NUCLEUS; MOUSE; NONHUMAN; PREOPTIC NUCLEUS; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR BINDING; RECEPTOR DENSITY; SIGNAL TRANSDUCTION; SOLITARY TRACT NUCLEUS; THALAMUS MIDLINE NUCLEUS; WILD TYPE;

ANESTHESIA; ANGIOTENSINOGEN; ANGIOTENSINS; ANIMALS; BINDING SITES; BLOOD PRESSURE; GLUTAMIC ACID; HEART RATE; MEDULLA OBLONGATA; MICE; MICE, KNOCKOUT; MICROINJECTIONS; PHENYLEPHRINE; RECEPTOR, ANGIOTENSIN, TYPE 1; VASOCONSTRICTOR AGENTS;

EID: 75449112397     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00462.2009     Document Type: Article

References (47)

1. Alexiou T, Boon WM, Denton DA, Nicolantonio RD, Walker LL, McKinley MJ, Campbell DJ. Angiotensinogen and angiotensin-converting enzyme gene copy number and angiotensin and bradykinin peptide levels in mice. J Hypertens 23: 945-954, 2005.
2. Allen AM, Dampney RA, Mendelsohn FA. Angiotensin receptor binding and pressor effects in cat subretrofacial nucleus. Am J Physiol Heart Circ Physiol 255: H1011-H1017, 1988.
3. Allen AM, Moeller I, Jenkins TA, Zhuo J, Aldred GP, Chai SY, Mendelsohn FA. Angiotensin receptors in the nervous system. Brain Res Bull 47: 17-28, 1998.
4. Allen AM, Zhuo J, Mendelsohn FA. Localization and function of angiotensin AT1 receptors. Am J Hypertens 13: 31S-38S, 2000.
5. Andreatta SH, Averill DB, Santos RA, Ferrario CM. The ventrolateral medulla. A new site of action of the renin-angiotensin system. Hypertension 11: I163-166, 1988.
6. Baltatu O, Fontes MA, Campagnole-Santos MJ, Caligiorni S, Ganten D, Santos RA, Bader M. Alterations of the renin-angiotensin system at the RVLM of transgenic rats with low brain angiotensinogen. Am J Physiol Regul Integr Comp Physiol 280: R428-R433, 2001.
7. Baltatu O, Janssen BJ, Bricca G, Plehm R, Monti J, Ganten D, Bader M. Alterations in blood pressure and heart rate variability in transgenic rats with low brain angiotensinogen. Hypertension 37: 408-413, 2001.
8. Blasioli J, Kladis A, Clarke IJ, Campbell DJ. Sheep hypothalamus contains a non-angiotensin ligand for type 1 and type 2 angiotensin II receptors. Clin Exp Pharmacol Physiol 20: 555-562, 1993.
9. Chen X, Cui Z, Zhang F, Chang W, Chen L, Liu L. Angiotensin II and cAMP regulate AT(1)-mRNA expression in rat cardiomyocytes by transcriptional mechanism. Eur J Pharmacol 448: 1-9, 2002.
10. Clauser E, Curnow KM, Davies E, Conchon S, Teutsch B, Vianello B, Monnot C, Corvol P. Angiotensin II receptors: protein and gene structures, expression and potential pathological involvements. Eur J Endocrinol 134: 403-411, 1996.
11. Dampney RA, Tan PS, Sheriff MJ, Fontes MA, Horiuchi J. Cardiovascular effects of angiotensin II in the rostral ventrolateral medulla: the push-pull hypothesis. Curr Hypertens Rep 9: 222-227, 2007.
12. Elton TS, Martin MM. Alternative splicing: a novel mechanism to fine-tune the expression and function of the human AT1 receptor. Trends Endocrinol Metab 14: 66-71, 2003.
13. Elton TS, Martin MM. Angiotensin II type 1 receptor gene regulation: transcriptional and posttranscriptional mechanisms. Hypertension 49: 953-961, 2007.
14. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. San Diego: Academic, 2004.
15. Gembardt F, Heringer-Walther S, van Esch JH, Sterner-Kock A, van Veghel R, Le TH, Garrelds IM, Coffman TM, Danser AH, Schultheiss HP, Walther T. Cardiovascular phenotype of mice lacking all three subtypes of angiotensin II receptors. FASEB J 22: 3068-3077, 2008.
16. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 7: 335-346, 2006.
17. Hauser W, Johren O, Saavedra JM. Characterization and distribution of angiotensin II receptor subtypes in the mouse brain. Eur J Pharmacol 348: 101-114, 1998.
18. Hirooka Y, Potts PD, Dampney RA. Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla of the rabbit. Brain Res 772: 107-114, 1997.
19. + and ouabain are attenuated in transgenic rats deficient in brain angiotensinogen. Hypertension 37: 683-686, 2001.
20. Ishida J, Sugiyama F, Tanimoto K, Taniguchi K, Syouji M, Takimoto E, Horiguchi H, Murakami K, Yagami K, Fukamizu A. Rescue of angiotensinogen-knockout mice. Biochem Biophys Res Commun 252: 610-616, 1998.
21. Jenkins TA, Chai SY, Mendelsohn FA. Upregulation of angiotensin II AT1 receptors in the mouse nucleus accumbens by chronic haloperidol treatment. Brain Res 748: 137-142, 1997.
22. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo AP, Hata A, Corvol P, Lalouel JM. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 60: 1448-1460, 1997.
23. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette JC, Coffman TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 92: 2735-2739, 1995.
24. Kohara K, Brosnihan KB, Ferrario CM, Milsted A. Peripheral and central angiotensin II regulates expression of genes of the renin-angiotensin system. Am J Physiol Endocrinol Metab 262: E651-E657, 1992.
25. Lassegue B, Alexander RW, Nickenig G, Clark M, Murphy TJ, Griendling KK. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. Mol Pharmacol 48: 601-609, 1995.
26. Li P, Sur SH, Mistlberger RE, Morris M. Circadian blood pressure and heart rate rhythms in mice. Am J Physiol Regul Integr Comp Physiol 276: R500-R504, 1999.
27. MacGregor DP, Murone C, Song K, Allen AM, Paxinos G, Mendelsohn FA. Angiotensin II receptor subtypes in the human central nervous system. Brain Res 675: 231-240, 1995.
28. Massiera F, Seydoux J, Geloen A, Quignard-Boulange A, Turban S, Saint-Marc P, Fukamizu A, Negrel R, Ailhaud G, Teboul M. Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity. Endocrinology 142: 5220-5225, 2001.
29. McKinley MJ, McAllen RM, Pennington GL, Smardencas A, Weisinger RS, Oldfield BJ. Physiological actions of angiotensin II mediated by AT1 and AT2 receptors in the brain. Clin Exp Pharmacol Physiol Suppl 3: S99-S104, 1996.
30. McKinley MJ, Walker LL, Alexiou T, Allen AM, Campbell DJ, Di Nicolantonio R, Oldfield BJ, Denton DA. Osmoregulatory fluid intake but not hypovolemic thirst is intact in mice lacking angiotensin. Am J Physiol Regul Integr Comp Physiol 294: R1533-R1543, 2008.
31. Moellenhoff E, Blume A, Culman J, Chatterjee B, Herdegen T, Lebrun CJ, Unger T. Effect of repetitive icv injections of ANG II on c-Fos and AT(1)-receptor expression in the rat brain. Am J Physiol Regul Integr Comp Physiol 280: R1095-R1104, 2001.
32. Monti J, Schinke M, Bohm M, Ganten D, Bader M, Bricca G. Glial angiotensinogen regulates brain angiotensin II receptors in transgenic rats TGR(ASrAOGEN). Am J Physiol Regul Integr Comp Physiol 280: R233-R240, 2001.
33. Muratani H, Averill DB, Ferrario CM. Effect of angiotensin II in ventrolateral medulla of spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 260: R977-R984, 1991.
34. Nakamura A, Iwao H, Fukui K, Kimura S, Tamaki T, Nakanishi S, Abe Y. Regulation of liver angiotensinogen and kidney renin mRNA levels by angiotensin II. Am J Physiol Endocrinol Metab 258: E1-E6, 1990.
35. Nickenig G, Murphy TJ. Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells. Mol Pharmacol 50: 743-751, 1996.
36. Niimura F, Matsusaka T, Ichikawa I. Evidence for the role of angiotensin in the establishment and maintenance of renal morphology. Contrib Nephrol 118: 234-237, 1996.
37. Pohl M, Carayon A, Cesselin F, Hamon M. Angiotensin II-like material extracted from the rat brain is distinct from authentic angiotensin II. J Neurochem 51: 1407-1413, 1988.
38. Sandberg K, Ji H, Catt KJ. Regulation of angiotensin II receptors in rat brain during dietary sodium changes. Hypertension 23: I137-I141, 1994.
39. Sasaki S, Dampney RA. Tonic cardiovascular effects of angiotensin II in the ventrolateral medulla. Hypertension 15: 274-283, 1990.
40. Schinke M, Baltatu O, Bohm M, Peters J, Rascher W, Bricca G, Lippoldt A, Ganten D, Bader M. Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen. Proc Natl Acad Sci USA 96: 3975-3980, 1999.
41. Sechi LA, Griffin CA, Giacchetti G, Valentin JP, Llorens-Cortes C, Corvol P, Schambelan M. Tissue-specific regulation of type 1 angiotensin II receptor mRNA levels in the rat. Hypertension 28: 403-408, 1996.
42. Silva LC, Fontes MA, Campagnole-Santos MJ, Khosla MC, Campos RR Jr, Guertzenstein PG, and Santos RA. Cardiovascular effects produced by micro-injection of angiotensin-(1-7) on vasopressor and vasodepressor sites of the ventrolateral medulla. Brain Res 613: 321-325, 1993.
43. Sumners C, Fleegal MA, Zhu M. Angiotensin AT1 receptor signalling pathways in neurons. Clin Exp Pharmacol Physiol 29: 483-490, 2002.
44. Tamura K, Umemura S, Sumida Y, Nyui N, Kobayashi S, Ishigami T, Kihara M, Sugaya T, Fukamizu A, Miyazaki H, Murakami K, Ishii M. Effect of genetic deficiency of angiotensinogen on the renin-angiotensin system. Hypertension 32: 223-227, 1998.
45. Tamura K, Yokoyama N, Sumida Y, Fujita T, Chiba E, Tamura N, Kobayashi S, Kihara M, Murakami K, Horiuchi M, Umemura S. Tissue-specific changes of type 1 angiotensin II receptor and angiotensin-converting enzyme mRNA in angiotensinogen gene-knockout mice. J Endocrinol 160: 401-408, 1999.
46. Tanimoto K, Sugiyama F, Goto Y, Ishida J, Takimoto E, Yagami K, Fukamizu A, Murakami K. Angiotensinogen-deficient mice with hypotension. J Biol Chem 269: 31334-31337, 1994.
47. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45: 205-251, 1993.